erythromycin-A
Test Ligands Values Explained
- Test Ligand ID - A unique identifier for the test ligand
- Ligand Name - Name of the test ligand
Test Ligand ID | 6110 |
---|---|
Ligand Name | erythromycin-A |
PubMed Compound Id | 12560 |
Structure | |
Molecular Formula | C37H67NO13 |
Molecular Weight | 733.9 |
SMILES | CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O |
Synonyms | erythromycin 114-07-8 Erythromycin A E-Mycin Abomacetin Erythromycinum Emgel Eritromicina Erythromycine Robimycin Torlamicina Eryderm Erythro-Statin Erythromycin base E-Glades Ery-Tab Pantomicina Erygel Sansac E-Base Erythra-Derm ERYC Dumotrycin Mephamycin Ermycin Eryacne Stiemycin Aknin Erycen Wemid R-P Mycin Eryc Sprinkles Theramycin Z E-Solve 2 Ak-Mycin Erythromast 36 Erytrociclin Acneryne Endoeritrin Eritomicina Eryacnen Erydermer Eryhexal Erythroderm Iloticina Latotryd Lederpax Oftamolets Pantoderm Pantodrin Pharyngocin Primacine Proterytrin Stiemicyn Tiprocin Acnesol Derimer Deripil Emuvin Emycin Erecin Erisone Erymed Erysafe Erytab Erytop Inderm Mercina Romycin AustriaS Eros C-Solve-2 Ery-maxin Erythro-Teva Sans-acne Erimycin-T Ery-Diolan Inderm Gel Del-Mycin Udima Ery Gel Aknederm Ery Gel Abboticin Emu-Ve Akne Cordes Losung Eryc 125 Ilotycin T.S. Skid Gel E E-Mycin (base) Emu-V Ery-B Ery-Tab (base) E-Base (base) ERYC (base) erythromycin-A A/T/S Erythrogran Erythroguent Erythromid Propiocine Dotycin Erycinum Ilocaps PCE Dispertab (base) Erycin Kesso-Mycin Eryc-125 Eryc-250 Taimoxin-F Oftalmolosa Cusi Eritromicina Staticin Retcin erthromycin Sentry AQ mardel maracyn Eritromicina [INN-Spanish] Erythromycine [INN-French] Erythromycinum [INN-Latin] CCRIS 9078 DTXSID4022991 UNII-63937KV33D CHEBI:42355 HSDB 3074 EM-A EINECS 204-040-1 NSC 55929 NSC-55929 PCE (ERYTHROMYCIN) 63937KV33D AI3-50138 DTXCID102991 EC 204-040-1 Erythromycin [USP:INN:BAN:JAN] NSC55929 ERY BENZAMYCIN COMPONENT ERYTHROMYCIN Eritromicina (INN-Spanish) Erythromycine (INN-French) Erythromycinum (INN-Latin) ERYTHROMYCIN (MART.) ERYTHROMYCIN [MART.] ERYTHROMYCIN (USP-RS) ERYTHROMYCIN [USP-RS] ERYTHROMYCIN (EP MONOGRAPH) Erythromycin (USP:INN:BAN:JAN) ERYTHROMYCIN [EP MONOGRAPH] ERYTHROMYCIN (USP MONOGRAPH) ERYTHROMYCIN [USP MONOGRAPH] Spotex ErythromycinBase Gallimycin-36 ErythromycinBase Filmtab Erythro-100 Injection API E.M. Erythromycin Erythromycin Base Filmtab Erythro-36, Erythro-Dry API E.M ERYTHROMYCIN CHEBI:48923 Gallimycin Injection, Gallimycin-100 ERYTHROMYCIN COMPONENT OF BENZAMYCIN 204-040-1 rp-mycin Erymax Ilotycin Erythrocin Erycette Akne-Mycin T-Stat erythro Eritrocina MFCD00084654 Benzamycin CHEMBL532 J01FA01 (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione Erythromycin C-13 Aknemycin 8HPH7ND0LN (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione Ilosone (estolate) N-Methylerythromycin A Erythromycin, labeled with carbon-13 Staticin (TN) Akne-mycin (TN) Erygel (TN) Eryc (TN) T-stat (TN) Pce (TN) SR-05000001618 Erythromycin & VRC3375 82343-12-2 NCGC00094670-01 (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione CAS-114-07-8 Prestwick_205 215031-94-0 Spectrum_000115 Spectrum_000659 Prestwick3_000151 Spectrum2_000759 Spectrum2_001263 Spectrum4_000538 Spectrum5_001596 UNII-8HPH7ND0LN ERYTHROMYCIN [MI] E0751 Erythromycin A, B + C ERYTHROMYCIN [INN] ERYTHROMYCIN [JAN] ERYTHROMYCIN [HSDB] SCHEMBL2601 ERYTHROMYCIN [VANDF] BSPBio_000282 BSPBio_002480 KBioGR_001175 KBioSS_000555 KBioSS_001139 MLS001066618 BIDD:GT0017 DivK1c_000294 DivK1c_000397 DivK1c_000702 ERYTHROMYCIN [WHO-DD] ERYTHROMYCIN [WHO-IP] SPECTRUM1500280 SPBio_000778 SPBio_001226 E-Base;E-Mycin;Erytromycin A BPBio1_000312 GTPL1456 Erythromycin (JP18/USP/INN) HMS500O16 KBio1_000294 KBio1_000397 KBio1_000702 KBio2_000555 KBio2_001139 KBio2_003123 KBio2_003707 KBio2_005691 KBio2_006275 ERYTHROMYCIN [GREEN BOOK] MSK7801 NINDS_000294 NINDS_000397 NINDS_000702 ERYTHROMYCIN [ORANGE BOOK] HMS1920M04 HMS2091D05 HMS2095O04 HMS3712O04 Pharmakon1600-01500280 HY-B0220 RKL10096 Tox21_111311 Tox21_111869 Tox21_300515 BDBM50344942 CCG-38992 LMPK04000006 NSC756759 ERYTHROMYCINUM [WHO-IP LATIN] AKOS015895249 AE22796 DB00199 NSC-756759 IDI1_000294 IDI1_000397 IDI1_000702 SMP1_000119 NCGC00179619-01 NCGC00179619-02 NCGC00179619-03 NCGC00254234-01 AC-12744 AC-12901 SMR000544946 Erythromycin, potency: >=850 mug per mg Erythromycin, tested according to Ph.Eur. SBI-0051368.P003 Erythromycin, N-demethyl-N-(methyl-11C)- Erythromycin 1000 microg/mL in Acetonitrile NS00000203 Erythromycin, meets USP testing specifications C01912 D00140 AB00051981_09 AB00051981_10 Erythromycin, Biotechnology Performance Certified Erythromycin estolate impurity, free erythromycin- Q213511 SR-01000799155 Erythromycin, BioReagent, suitable for cell culture SR-01000799155-2 SR-05000001618-1 SR-05000001618-2 BRD-K63550407-001-12-7 BRD-K63550407-001-13-5 BRD-K63550407-028-03-9 BRD-K63550407-028-04-7 Z2587996953 Erythromycin A, European Pharmacopoeia (EP) Reference Standard Erythromycin, United States Pharmacopeia (USP) Reference Standard ERYTHROMYCIN ESTOLATE IMPURITY, FREE ERYTHROMYCIN [EP IMPURITY] ERYTHROMYCIN ESTOLATE IMPURITY, FREE ERYTHROMYCIN- [USP IMPURITY] Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name) [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-|A-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-|A-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione 7540-22-9 |
Created At | Jan 13, 2025 2:47 pm |
Updated At | Jan 13, 2025 2:47 pm |